Literature DB >> 25541256

In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.

C S Shobana1, A Mythili2, M Homa3, L Galgóczy3, R Priya2, Y R Babu Singh2, K Panneerselvam4, C Vágvölgyi3, L Kredics3, V Narendran5, P Manikandan6.   

Abstract

OBJECTIVE: The in vitro antifungal activities of azole drugs viz., itraconazole, voriconazole, ketoconazole, econazole and clotrimazole were investigated in order to evaluate their efficacy against filamentous fungi isolated from mycotic keratitis.
METHODS: The specimen collection was carried out from fungal keratitis patients attending Aravind eye hospital and Post-graduate institute of ophthalmology, Coimbatore, India and was subsequently processed for the isolation of fungi. The dilutions of antifungal drugs were prepared in RPMI 1640 medium. Minimum inhibitory concentrations (MICs) were determined and MIC50 and MIC90 were calculated for each drug tested.
RESULTS: A total of 60 fungal isolates were identified as Fusarium spp. (n=30), non-sporulating moulds (n=9), Aspergillus flavus (n=6), Bipolaris spp. (n=6), Exserohilum spp. (n=4), Curvularia spp. (n=3), Alternaria spp. (n=1) and Exophiala spp. (n=1). The MICs of ketoconazole, clotrimazole, voriconazole, econazole and itraconazole for all the fungal isolates ranged between 16 μg/mL and 0.03 μg/mL, 4 μg/mL and 0.015 μg/mL, 8 μg/mL and 0.015 μg/mL, 8 μg/mL and 0.015 μg/mL and 32 μg/mL and 0.06 μg/mL respectively. From the MIC50 and MIC90 values, it could be deciphered that in the present study, clotrimazole was more active against the test isolates at lower concentrations (0.12-5 μg/mL) when compared to other drugs tested.
CONCLUSION: The results suggest that amongst the tested azole drugs, clotrimazole followed by voriconazole and econazole had lower MICs against moulds isolated from mycotic keratitis.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antifungal susceptibility and azole drugs; Fungal isolates; Kératite mycosique; Mycotic keratitis; Médicaments azolés; Sensibilité aux antifongique

Mesh:

Substances:

Year:  2014        PMID: 25541256     DOI: 10.1016/j.mycmed.2014.10.024

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  4 in total

1.  Successful treatment of Chrysosporium keratitis with voriconazole.

Authors:  Onsiri Thanathanee; Chavakij Bhoomibunchoo; Orapin Anutarapongpan; Olan Suwan-Apichon; Yosanan Yospaiboon
Journal:  Int Med Case Rep J       Date:  2017-03-20

2.  South Indian Isolates of the Fusarium solani Species Complex From Clinical and Environmental Samples: Identification, Antifungal Susceptibilities, and Virulence.

Authors:  Mónika Homa; László Galgóczy; Palanisamy Manikandan; Venkatapathy Narendran; Rita Sinka; Árpád Csernetics; Csaba Vágvölgyi; László Kredics; Tamás Papp
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

3.  A Composite System Based upon Hydroxypropyl Cyclodextrins and Soft Hydrogel Contact Lenses for the Delivery of Therapeutic Doses of Econazole to the Cornea, In Vitro.

Authors:  Anepmete Wong; Melissa Fallon; Vildan Celiksoy; Salvatore Ferla; Carmine Varricchio; David Whitaker; Andrew J Quantock; Charles M Heard
Journal:  Pharmaceutics       Date:  2022-08-04       Impact factor: 6.525

Review 4.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.